HELLP syndrome (HELLP), third trimester
ICD-10 O14.23 is a billable code used to indicate a diagnosis of hellp syndrome (hellp), third trimester.
HELLP syndrome is a severe form of pre-eclampsia characterized by hemolysis, elevated liver enzymes, and low platelet count. It typically occurs in the third trimester of pregnancy, often after the 20th week, and can lead to serious complications for both the mother and fetus if not promptly diagnosed and managed. The condition is associated with severe features of pre-eclampsia, including hypertension and proteinuria. Symptoms may include abdominal pain, nausea, vomiting, and headache. The pathophysiology involves placental dysfunction leading to systemic endothelial activation and inflammatory responses. Management often requires immediate delivery of the fetus, especially if the mother exhibits severe symptoms or laboratory abnormalities. Magnesium sulfate is frequently administered to prevent seizures, and careful monitoring of liver function and platelet counts is essential. The timely recognition and treatment of HELLP syndrome are critical to improving maternal and fetal outcomes.
Detailed records of blood pressure readings, proteinuria, and laboratory results are essential for accurate coding.
Patients presenting with severe headaches, visual disturbances, or abdominal pain in the third trimester.
Coders must be aware of the nuances in coding severe features of pre-eclampsia and HELLP syndrome.
Comprehensive documentation of maternal and fetal monitoring, including ultrasound findings and fetal heart rate patterns.
Management of high-risk pregnancies with multiple complications, including HELLP syndrome.
High-risk coding requires attention to detail in documenting maternal health and fetal outcomes.
Used for fetal assessment in cases of HELLP syndrome.
Document indications for amniocentesis and fetal monitoring.
Considerations for maternal safety and fetal well-being.
Key symptoms include severe abdominal pain, nausea, vomiting, headache, and visual disturbances, along with laboratory findings of hemolysis, elevated liver enzymes, and low platelet count.
